AzTrials
AzTrials

Mechanical Ventilation WeaningECHODIAPH IINCT02883465

Ultrasound Diagnostic for Diaphragmatic Dysfunction in Reanimation

A study testing Diaphragmatic ultrasound in people with Mechanical Ventilation Weaning, run by Centre Hospitalier Saint Joseph Saint Luc de Lyon at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Extubation is a crucial step when patients are being weaned from mechanical ventilator support. Indeed, the patient has to face an increasing burden imposed to the ventilation system. The ability to overcome this event will determine the patient survival. A warning signal could be very useful is this situation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mechanical Ventilation Weaning
What is being tested?
Diaphragmatic ultrasound
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
3 sitesFrance
Study dates
6 Mar 2015to 1 Nov 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Successful spontaneous breathing trial and extubation expected on the same day and 1 of the following criteria :
  • Age > 65
  • Mechanical ventilation during > 7 days
  • Cardiac history (ischemic, rhythmic or valve cardiopathy)
  • Respiratory history (documented or likely chronic respiratory failure)

Who cannot join

  • Patient who is tracheotomized
  • Peripheric neuromuscular disease (myasthenia, myopathy)
  • Surgery circumstances that could affect the quality of the ultrasound exam (drains or bandages)
  • Pregnant woman
  • Age < 18

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • Centre Hospitalier Saint Joseph Saint Luc

    Lyon, 69007

  • Centre Hospitalier Annecy Genevois

    Metz-Tessy, 74374

  • Centre Hospitalier Universitaire de Poitiers

    Poitiers, 86021

Other trials in France

About this study

Official title: Ultrasound Diagnostic for Diaphragmatic Dysfunction in Reanimation and Influence Over Mechanical Ventilation Weaning Period

Extubation is a crucial step when patients are being weaned from mechanical ventilator support. Indeed, the patient has to face an increasing burden imposed to the ventilation system. The ability to overcome this event will determine the patient survival. A warning signal could be very useful is this situation. 2 recent studies have shown that measuring diaphragmatic cupolas and muscular fibers thickening fraction could help to spot a population with a high risk of "diaphragmatic weakness", characterized by a high failure extubation rate. This study aims to verify that this kind of group of patients does exist.

Being tested
Diaphragmatic ultrasound
Keywords
diaphragmatic dysfunction, mechanical ventilation weaning, failure extubation rate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diaphragmatic ultrasoundProcedure or surgery

    All patients will have a diaphragmatic ultrasound in the 4 hours before the extubation.

    • a record of the right and left diaphragmatic cupolas run, with a chest approach and using a 4-5 MHz (megahertz) cardiac or abdominal sensor. 3 acquisitions for each side
    • a record of the diaphragm thickening at the right and left apposition zones with a 10-12 MHz (megahertz) vascular sensor. 3 acquisitions for each side
Study groups in NCT02883465
Study groupRoleWhat they receive
Single armOtherNot described
Receives: Procedure: Diaphragmatic ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extubation success rate

    Extubation success rate, defined as no reintubation 7 days after the reporting extubation

    Measured: 7 days after the reported extubation

Secondary outcomes (13)
  1. Length of stay in reanimation unit (days)

    Measured: At discharge of reanimation unit (up to 1 year)

  2. Length of mechanical ventilation

    Measured: At the extubation time

  3. Number of patients with invasive or non-invasive mechanical ventilation

    Resort to invasive or non-invasive mechanical ventilation

    Measured: 48 hours after the extubation

  4. Mortality

    Measured: At discharge of reanimation unit (up to 1 year)

  5. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a clinical parameter : cough strength measured with a defined scale

    The scale used to measure the cough is the following :

    • absent
    • inefficient
    • low efficiency
    • mild efficiency
    • efficient

    Measured: At the extubation time

  6. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a clinical parameter : quantity of secretions measured with a defined scale

    • any secretions
    • low secretions
    • mild secretions
    • abundant secretions
    • very abundant secretions

    Measured: At the extubation time

  7. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a clinical parameter : presence/absence or cervical tonus

    Measured: At the extubation time

  8. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a clinical parameter : F/Vt ratio measured in breaths/min/L

    Measured: At the extubation time

  9. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a paraclinical parameter : maximal inspiratory pressure in centimeters of water

    Measured: At the extubation time

  10. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a paraclinical parameter : minimal expiratory pressure measured in centimeters of water

    Measured: At the extubation time

  11. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a paraclinical parameter : peak flow measured in L/min (liters per minute)

    Measured: At the extubation time

  12. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a paraclinical parameter : peak flow when coughing measured in L/min (liters per minute)

    Measured: At the extubation time

  13. Comparison between the predictive value of diaphragmatic ultrasound dysfunction and a paraclinical parameter : P0,1 measured in milliseconds

    Measured: At the extubation time

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2016 (estimated)
  2. Study start6 Mar 2015
  3. Primary completion28 Oct 2016
  4. Study completion1 Nov 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02883465
Sponsor's protocol ID
SJSL12014
Acronym
ECHODIAPH II
Status last verified
Apr 2024
First submitted
27 May 2016
Last updated
4 Apr 2024
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Diaphragmatic ultrasound in people with Mechanical Ventilation Weaning, run by Centre Hospitalier Saint Joseph Saint Luc de Lyon at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Extubation success rate (time frame: 7 days after the reported extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in